The post argues tirzepatide is a prescription drug that calls for careful patient assessment and clinical knowledge, not just an injection.
Recap by typeshit. Post by Facebook on Facebook.
Reuters reports the trend among GLP-1 users is prompting calls for tighter rules on supplements sold alongside the drugs.
A pharmacist account flags two separate Class II recalls involving compounded tirzepatide. Tap through for which products are affected and why.
Health authorities in New South Wales issued a warning after a jump in hospitalisations linked to unapproved peptides sold as wellness products.
A University of Iowa chemist found no peptide in a Brooklyn corner-store vial, and another expert flagged at least 13 bacterial colonies that could cause infection.
Writing for Adgully, Paliwal looks at how shifting appetites from GLP-1 use are changing wellness spending in India.
The Indian actor shares his take on weight loss drugs and explains why he still sees exercise as essential to staying fit.
Loading…